PG(O-16:0/22:4(7Z,10Z,13Z,16Z))

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hexadecoxypropan-2-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate

MGHLVJXBBBQZLA-PTQJDVFGSA-N CHEBI:187605 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: MGHLVJXBBBQZLA-PTQJDVFGSA-N
InChI Key: MGHLVJXBBBQZLA-PTQJDVFGSA-N
IUPAC name: [(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hexadecoxypropan-2-yl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate
Preferred name: PG(O-16:0/22:4(7Z,10Z,13Z,16Z))
INN name: —
Synonym: —
ChEBI: CHEBI:187605

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release

Observed in differential profiles

Control_16.6_months_vs_Treatment_16.6_months